Terms: = Lung cancer AND DROSHA, HSA242976, 29102, RNASEN, ENSG00000113360, Q9NRR4, RNASE3L, RN3, RANSE3L, Etohi2 AND Prognosis
4 results:
1. Diagnostic value of plasma expression of microRNAs complementary to drosha and Dicer in lung cancer patients.
Szczyrek M; Kuźnar-Kamińska B; Grenda A; Krawczyk P; Sawicki M; Głogowski M; Balicka G; Rolska-Kopińska A; Nicoś M; Jakimiec M; Batura-Gabryel H; Kowalski DM; Mlak R; Krzakowski M; Milanowski J
Eur Rev Med Pharmacol Sci; 2019 May; 23(9):3857-3866. PubMed ID: 31115013
[TBL] [Abstract] [Full Text] [Related]
2. MicroRNA-related genetic variants associated with clinical outcomes in early-stage non-small cell lung cancer patients.
Pu X; Roth JA; Hildebrandt MA; Ye Y; Wei H; Minna JD; Lippman SM; Wu X
Cancer Res; 2013 Mar; 73(6):1867-75. PubMed ID: 23378343
[TBL] [Abstract] [Full Text] [Related]
3. DICER1, drosha and miRNAs in patients with non-small cell lung cancer: implications for outcomes and histologic classification.
Díaz-García CV; Agudo-López A; Pérez C; López-Martín JA; Rodríguez-Peralto JL; de Castro J; Cortijo A; Martínez-Villanueva M; Iglesias L; García-Carbonero R; Fresno Vara JA; Gámez-Pozo A; Palacios J; Cortés-Funes H; Paz-Ares L; Agulló-Ortuño MT
Carcinogenesis; 2013 May; 34(5):1031-8. PubMed ID: 23349018
[TBL] [Abstract] [Full Text] [Related]
4. Reduced expression of Dicer associated with poor prognosis in lung cancer patients.
Karube Y; Tanaka H; Osada H; Tomida S; Tatematsu Y; Yanagisawa K; Yatabe Y; Takamizawa J; Miyoshi S; Mitsudomi T; Takahashi T
Cancer Sci; 2005 Feb; 96(2):111-5. PubMed ID: 15723655
[TBL] [Abstract] [Full Text] [Related]
